September 18, 2012 — Neovasc Inc. announced that acute results from preclinical studies of its Tiara valve for the transcatheter treatment of mitral regurgitation were published in the ...
Cardiologists are restricting the use of transcatheter aortic valve implantation (TAVI) to very old or very sick patients at high surgical risk, according to research presented at the European...
The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report investigations that will be presented at next month's...
Medtronic has reached two clinical program milestones for its CoreValve system in the United States. It completed enrollment in its study of high-risk patients in its CoreValve U.S. Pivotal...
August 17, 2012 —Xeridiem, a vertically integrated OEM that designs, develops and manufactures complex single-use medical devices, announced it will provide LoneStar Heart Inc. with...
Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a transfemoral combined access and...
Interventional procedures are growing rapidly and becoming more specialized in diverse areas of care. In the next decade, the number of people living in the United States who have heart...
Trends and new technology for cardiac computed tomography angiography (CCTA) were highlighted during the 2012 Society of Cardiovascular CT (SCCT) annual scientific meeting in July in Baltimore, Md...
July 23, 2012 — Medtronic Inc. announced the first patient enrollment in a clinical trial comparing the CoreValve system with surgical aortic valve replacement in patients with severe aortic...
July 16, 2012 — Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe...
July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug Administration (FDA) approval...
June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million...
June 20, 2012 — Echocardiography is playing a key role in both the assessment and guidance of transcatheter aortic valve replacement (TAVR). Attendees at the American Society of...
June 18, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the Amplatzer Vascular Plug 4 (AVP 4) for use in...
June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Dexterity Steerable Introducer, a next-generation...
June 15, 2012 — CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self-anchoring technology for nonsurgical transcatheter mitral valve implantation (...
June 14, 2012 — A U.S. Food and Drug Administration (FDA) advisory panel voted in favor of recommending expanding the indication for the Edwards Lifesciences Sapien...
June 4, 2012 — MitrAssist Medical Ltd., a developer of minimally invasive products for treating heart disease, announced today it received ISO 13485:2003 certification for the design and...
June 1, 2012 — LoneStar Heart Inc. announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts into functioning heart...
May 31, 2012 —Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, announced receiving a favorable...
May 23, 2012 — Edwards Lifesciences Corp. announced that data from its post-approval study involving 94 European centers performing transcatheter aortic valve replacement (TAVR) demonstrated...
May 22, 2012 — CardioKinetix Inc. announced two-year clinical results for the first-of-its-kind catheter-based Parachute ventricular partitioning device, a percutaneous ventricular restoration (...
May 21, 2012 -- Boston Scientific Corp. announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus Aortic Valve System in patients with severe...
May 15, 2012 — In a keynote Founders’ Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Session on May 10, Ted Feldman, M.D., FSCAI, highlighted how...
May 14, 2012 — Boston Scientific announced results from the ASA Plavix (ASAP) Study, which studied the Watchman Left Atrial Appendage (LAA) Closure device. The data showed a reduction in the risk...
May 8, 2012 – The team at Texas Children's Fetal Center has successfully completed two in-utero fetal cardiac interventions to treat hypoplastic left heart syndrome (HLHS), a congenital heart...
May 4, 2012 - Edwards Lifesciences Corp. announced that new data from the European multi-center Triton trial studying the Edwards Intuity valve system highlights the promise of several important...
May 4, 2012 - SMT Research & Development Ltd. (SMT) announced the addition of three key executives to its management team, including a new CEO, CFO and chief medical officer, plus two...
May 1, 2012 – The Centers for Medicare and Medicaid Services (CMS) announced today it will now cover transcatheter aortic valve replacement (TAVR) for Medicare...
April 24, 2012 - SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO) — a platform for the percutaneous transcatheter closure of a heart defect...
April 23, 2012 - Boston Scientific Corp. announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System...
April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scientific meeting, May 17, in Paris.
April 19, 2012 - St. Jude Medical Inc., a global medical device company, announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and the launch of the Trifecta...
April 12, 2012 - Edwards Lifesciences Corp. said a U.S. Food and Drug Administration (FDA) advisory panel will review the company's request to expand the indication for the Sapien transcatheter...
April 4, 2012 — Edwards Lifesciences Corp. reported that longer-term results (≥ 2 years) from the high-risk Cohort A of the PARTNER Trial – a randomized comparison of patients treated with either...
Patients who underwent transcatheter aortic valve implantation (TAVI) at experienced medical centers had significant improvement in valve function as well as low mortality and stroke rates at 30...
A late-breaking stem cell trial presented at the American College of Cardiology (ACC)Annual Scientific Session showed only minor improvement in heart pumping...
March 29, 2012 — Non-cardiac co-morbidities such as chronic obstructive pulmonary disease, chronic kidney disease and frailty are the main predictors of late mortality after transcatheter aortic...
The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...
GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College...
March 19, 2012 – Individuals suffering from chronic heart failure (CHF) can look forward to the appearance of many new drug options over the next few years and place hope in a cure through future...
March 8, 2012 — Edwards Lifesciences Corp. reported March 3 it filed its official response to the Centers for Medicare and Medicaid Services (CMS) on its proposed national coverage determination (...
March 7, 2012 — Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial recommendations for creating and maintaining transcatheter aortic valve...
March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells...
February 20, 2012 — Edwards Lifesciences Corp. announced that it received CE mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (...
February 16, 2012 — Siemens Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for syngo Aortic ValveGuide, an integrated image processing software that helps...
February 3, 2012 — Colibri Heart Valve received an notification it received patents for a new transcatheter heart valve from the United States Patent and Trademark Office.
February 3, 2012 — Medtronic Inc. issued a statement on the results of two studies evaluating the use of the Medtronic CoreValve system delivered through the direct aortic implantation approach....
January 30, 2012 — Medtronic, Inc. announced the completion of patient enrollment in the extreme risk study in its CoreValve United States Pivotal Trial. The company received approval from the U.S...
The 2012 American College of Cardiology (ACC) meeting in Chicago, March 24-26, includes five sessions of late-breaking trials. The ACC announced the following trials will be included:
January 26, 2012 — Heart Hospital of Austin opened a heart valve clinic, the first of its kind in the region. The clinic gives new hope to patients with severe aortic stenosis who were previously...
January 26, 2012 — Amorcyte LLC, a NeoStem company, announced the enrollment of the first patient in the Amorcyte PreSERVE Phase II trial for acute myocardial infarction. The study is a...
January 25, 2012 — Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with LAAx Inc. to distribute the TigerPaw System II, a left atrial appendage (LAA)...
January 17, 2012 – Terumo Americas Holding Inc., a U.S. subsidiary of Japan's Terumo Corp., announced it acquired Onset Medical Corp., which develops interventional procedural access sheath...
January 13, 2012 — Amorcyte Inc., a NeoStem Inc. company, announced the expansion of intellectual property protection around its lead product candidate, AMR-001, with the grant of U.S. patent...
January 4, 2012 – ECRI, an independent nonprofit that researches the best approaches to improving patient care, listed 10 health technology issues that hospital leaders should have on their watch...
January 3, 2012 – Ikaria Inc. announced it commenced its global development program, the PRESERVATION I clinical trial, for its Bioabsorbable Cardiac Matrix (BCM). The CE mark registration trial...
December 28, 2011 – Edwards Lifesciences announced two-year results of a pivotal clinical study of inoperable patients with severe aortic stenosis treated with the Edwards Sapien transcatheter...
December 23, 2011 - Philips Healthcare said Medical City Dallas Hospital, Dallas, Texas, is the first hospital in the United States to use Philips’ HeartNavigator interventional tool in clinical...
December 20, 2011 – After a heart attack, the portions of the heart damaged by a lack of oxygen become scar tissue. Researchers have long sought ways to avoid this scarring, which can harden the...
December 20, 2011 –– Howie Lindeman was facing the loss of his career and Neim Malo wasn’t supposed to see 2011. They were each treated for heart disease years ago using their own stem cells to...
December 5, 2011 – University Hospitals Case Medical Center researchers could still be close to giving heart attack patients a second chance…just not as they originally thought.
November 18, 2011 – Boston Scientific’s Watchman left atrial appendage (LAA) closure device has been implanted in the first patients in Latin America. The device is designed for use in patients in...
November 18, 2011 – CorMatrix Cardiovascular Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company full investigational device exemption (IDE)...
Each year I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for the next big trend or technological innovations in cardiovascular devices. Below...
November 16, 2011 — Heart failure patients with a previous myocardial infarction showed an average of 12 percent improvement one year following an investigative treatment that infused them with...
November 15, 2011 — A two-year study of patients in the landmark PARTNER trial confirms the one-year findings and supports transcatheter aortic valve replacement (TAVR) as the standard-of-care.
November 15, 2011 – Results of the PARTNER Cohort A QOL study demonstrate that transcatheter aortic valve replacement (TAVR) results in improved quality of life compared with surgical valve...
November 14, 2011 — Edwards Lifesciences Corp. announced data were presented on the quality of life impact and cost effectiveness of transcatheter aortic valve replacement (TAVR) were presented at...
November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral regurgitation (MR) of functional etiology were presented at Transcatheter...
November 10, 2011 — Edwards Lifesciences Corp. announced the U.S. Food and Drug Administration (FDA) conditionally approved the addition of a second treatment group to the PARTNER II Trial. The...
Medtronic today announced it received CE (Conformité Européenne) mark for the CoreValve System to be delivered using direct aortic access. The Medtronic CoreValve System is now the only...
November 7, 2011 – Abbott announced the company's schedule of key data presentations at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, to be held Nov. 7 – 11...
